ServiziMenu principaleHome
You are here: Home > Who we are
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Mission and Vision

ESO group

Our Mission

The European School of Oncology is an independently funded non profit organisation dedicated to quality education and training, because we believe all patients deserve equal access to competent cancer care.

ESO was originally founded in 1982 by Umberto Veronesi and Laudomia Del Drago who were passionate about reducing the number of cancer deaths as a result of late diagnosis or inadequate treatment. Today we are continuing that passion by providing oncology education that helps improve the treatment of cancer patients. Through our extensive learning programmes, we’re reaching areas where education is most needed, both geographically and scientifically.

ESO lessons

Our Vision

To ensure that all cancer patients have access to unbiased and evidence-based competent care from adequately trained health professionals.

Strategic plan 2023-2025

Many things are changing in the global fight against cancer, ESO is looking ahead to the many  opportunities to increase the knowledge of health professionals in all fields of cancer medicine. Many things are changing in the global fight against cancer, ESO is looking ahead to the many  opportunities to increase the knowledge of health professionals in all fields of cancer medicine. 
We will do this by:

  1. Expanding ESO career development programmes: Masterclasses, Clinical Training Centres and Certificate Programmes. In the next 2 years ESO will support even more young and promising health professionals in the development of their career in cancer care. 
  2. Increasing educational activities in Eastern Europe, Balkan region and Eurasia. ESO plans to further reduce the gap between Western and Eastern Europe by improving the impact of its current activities, tackling access to textbooks and journals and developing Fellowships in Central/Eastern Europe. 
  3. Further developing and increasing of oncology e-learning courses and e-Sessions via e-ESO. ESO will strengthen e-ESO e-Sessions by improving user flexibility, opportunities for interaction and adapting to new technologies and communication tools. We know bolstering our online learning platform will help achieve our goal to enhance knowledge within our community.

Draft of the Strategic plan 2023-2025 is available HERE.

A PDF version of ESO's Code of Conduct is available HERE.


Umberto Veronesi, Milan


In 1982 Umberto Veronesi, a visionary in cancer care and treatment, alongside Laudomia Del Drago, a distinguished member of the Roman aristocracy and a breast cancer survivor, founded The European School of Oncology. They believed through increasing access to oncology education, cancer could not just be diagnosed sooner but treatment could improve, and in turn reduce the number of deaths.








Laudomia Del Drago, Rome

Honorary President

Leading oncologists from around the world joined the cause, playing a key role in the founding of ESO. They include Sir Michael Peckham, then a UK-based international leader in radiotherapy, best known for pioneering the technique of mantle field radiation; Franco Cavalli, a Swiss haematologist who led efforts to develop medical oncology as a recognised discipline in Europe, and was a founder member of the European Society for Medical Oncology; Louis Denis a urologist from Antwerp, who had been instrumental in setting up the European Organisation for Research and Treatment of Cancer; and Bob Pinedo, who at the time was co-editing Cancer Chemotherapy with Bruce Chabner, deputy director of the US National Cancer Institute, and was practising translational research at his Utrecht base in the Netherlands long before there was a word for it.

Michael Peckham


Franco Cavalli


Bob Pinedo


Louis Denis


Today, ESO is the one of the most established organisations exclusively dedicated to increasing the knowledge of health professionals in all fields of cancer medicine with the support of an international scientific committee and advisory board. Our partners and staff in Milan and Bellinzona, along with our supporters from all over the world, including the more than 1000 lecturers and experts and 20,000 alumni, continue to be fundamental to the on-going success of ESO. A more detailed history of ESO’s first 30 years can be found in Learning to Care: ESO at 30, which can be downloaded as a pdf HERE (7.5MB).


Board of Directors

Ugo Rock, Milan

Members Auditors
Marco Alloisio, Milan
Alberto Azario, Milan
Piergiuseppe Biandrino, Milan
Donella Bossi Pucci, Rome
Alberto Costa, Milan
Paola Favati, Milan
Vincenzo Finizzola, Milan
Thomas Galdy, Florence
Fedele Gubitosi, Milan (Vice President)
Laura Pellegrini, Rome
Marco B. Lovati, Milan (Chairman)
Barbara Negri, Milan
Stefano Sarubbi, Milan

Scientific Committee 2020-2022

Franco Cavalli, Bellinzona

Nicholas Pavlidis, Ioannina
Chairman elected

Alberto Costa, Milan
Chief Executive Officer

Fedro A. Peccatori, Milan
Scientific Director

Alexandru Eniu, Rennaz
Deputy Scientific Director


Matti Aapro, Geneva
Adriana Albini, Milan

Regina Beets Tan, Amsterdam
Felipe A. Calvo, Pamplona

Fatima Cardoso, Lisbon
Tanja Cufer, Ljubljana
Lesley Fallowfield, Brighton
Enriqueta Felip, Barcelona

Silke Gillessen, Bellinzona
Joseph Gligorov, Paris
Stan Kaye, Sutton
Holger Moch, Zurich
Peter Naredi, Göteborg

Demetris Papamichael, Nicosia
Christian Rolfo, New York
Lena Sharp (EONS), Stockholm 
Stephan Stilgenbauer, Ulm
Eric Van Cutsem, Leuven

Department Coordinators

Nicholas Pavlidis, Ioannina
Career development


Fedro A. Peccatori, Milan


Alexandru Eniu, Rennaz
ESCO - The ESO College


Franco Cavalli, Bellinzona
World Oncology Forum

 Scientific Advisers


Olivia Pagani, Bellinzona
Breast Cancer

Sara De Dosso, Bellinzona
Gastrointestinal Cancer

  Cristiana Sessa, Bellinzona
Gynaecologic Cancers

Alessandra Curioni, Zurich
Lung Cancer

Emanuele Zucca, Bellinzona

Ursula Vogl, Bellinzona
Prostate Cancer

Disclosure of potential conflict of interest
ESO’s initiatives and activities are defined by the ESO Executive Committee, the Scientific Committee and by the Department/Programme Coordinators.

For transparency, the ESO core collaborators declare potential conflict of interest that might rise in general when programmes are defined and developed.
The disclosures’ list is available here.



Fausta Amati


Valeria Barani

Communication Manager


Alice Ciocchini

Masterclass Programme - Executive Manager
CTC Fellowship Programme


Mariachiara Deleo

e-ESO - Podcasts and e-Courses Specialist

Sarah Goldman

e-ESO - e-Sessions Specialist



Corinne Hall

ESCO - Executive Manager

External Communication


 Dolores Knupfer

Cancer Disparities Programme - Executive Manager

Gabriele Maggini

Bellinzona Office Manager



Francesca Marangoni

Management Committee Coordinator
e-ESO - Executive Manager
Human Resources


Sarah Jane Ortelli Giannakis

Postgraduate Programmes - Certificate Organizer


Laura Richetti

Patients' Initiatives Coordinator


Alexandra Zampetti

Postgraduate Programmes - Executive Manager




Paola Favati

Financial and Legal Adviser


Michele Guerrieri

Legal Adviser


Lorenzo Pini

IT Manager


Samuel William Russell-Edu



e-ESO Team

Advisory Board

Dr Ramon Andrade Bezerra De Mello - Brazil

Dr Luca Bertolaccini - Italy

Dr Ilaria Colombo - Switzerland

Dr Iskra Daskalova - Russia

Dr Berardino De Bari - Switzerland

Dr Pierfrancesco Franco - Italy

Dr Wendy McInally - United Kingdom

Dr Astrid Pavlovsky - Argentina

 Team of Discussants

Dr Jonas Feilchenfeldt - Switzerland

Dr Patricia Fox - Ireland

Dr Gilberto Morgan - Sweden

Dr Marco Siano - Switzerland

Dr Wojciech Wysocki - Poland

 Team of ESCO Graduates


Dr Mohamed Emam Sobeih - Egypt

Dr Nicola Rocco - Italy

Dr Ehab Mahmoud - Saudi Arabia

Dr Narmin Talibova - Azerbaigian

Dr Assia Konsoulova - Bulgaria

Dr Simona Volovat - Romania

Dr Ana Tecic Vuger - Croatia
Dr Dorota Kwapisz - Poland
Dr Riham AbdelAziz - Egypt

Dr Hongcheng Zhu - China



ESO Ambassadors

The European School of Oncology wishes to express its gratitude to the ESO Ambassadors below who have committed themselves to help promote the school’s activities in their respective country. Having already taken part in one or more of ESO’s activities, they are able to share their own personal experience and inform oncologists about future ESO events and deadlines.

Dr Riham AbdelAziz
Dr Lajla Alidzanovic Nurkanovic
Bosnia and Herzegovina
Dr Elvina Almuradova

Dr Mikayel Arustamyan

Dr Tarek Assi

Dr Jose Maximo Barros

Dr Salome Begijanashvili

Dr Justyna Bochenek-Cibor

Dr Eduard-Alexandru Bonci
  Dr Simona Borilova
Czech Republic
Dr Silvia Brotea-Mosoiu
Dr Chiara Corti
Dr Bruna David
Dr Mohamed Emam Salah Emam Sobeih
Dr Tihana Gašpert
Dr Miloš Grujic
Dr Ivan Inkov

Dr Seyed Alireza Javadinia
Dr Alisher Kahharov
Dr Maximilian Kloft
   Dr Assia Konsoulova Kirova
Dr Anja Kovac
Dr Alvin Lee
United Kingdom
Dr Vadim Lesan
Dr Besmira Malaj
Dr Elena Manea
   Dr Elene Mariamidze
Dr Joana Marinho
Dr Leyla Mehmetbeyli
Dr Anna Mironova
Russian Federation
Dr Layth Mula-Hussain
Dr Elena Napolskaia
Russian Federation
Dr Malgorzata Osmola
Dr Karima Oualla
Dr Jana Pankovics
Dr Lazaros Papadopoulos
Dr Antonio Pellino
Dr Gordana Petkovska
Republic of North Macedonia
Dr Marina Puchinskaya

Dr Miroslawa Puskulluoglu

Dr Kleva Qeraj
Dr Daniela Shveid Gerson
  Dr Narmin Talibova
  Dr Mareike Thompson
United Kingdom
Dr Nataliia Verovkina
  Dr Slavica Zubcic



The European School of Oncology is a proud member of the European Cancer Organisation in Europe and of UICC internationally:

European Cancer Organisation

The European Cancer Organisation aims to reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, through multidisciplinarity and multiprofessionalism.
As the not-for-profit federation of member organisations working in cancer at a European level, the European Cancer Organisation convenes oncology professionals and patients to agree policy, advocate for positive change and speak up for the European cancer community.


Union for International Cancer Control (UICC)

The Union for International Cancer Control (UICC) unites and supports the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda.  
 The ESO Partners for the masterclasses are:

European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. 

European Oncology Nursing Society (EONS)

The European Oncology Nursing Society (EONS) is a pan-European membership organisation for cancer nurses with a current membership of almost 28,000 cancer nurses from all over Europe, the largest group of healthcare workers in the oncology workforce.
EONS provides leadership in all areas of cancer nursing: research, practice, continuing education, communications and advocacy for better recognition of cancer nursing across Europe.


International Society of Paediatric Oncology - Europe (SIOPE)

The European Society for Paediatric Oncology (SIOP Europe or SIOPE) is the only pan-European organisation representing all professionals working in the field of childhood cancers. With more than 2000 members across 36 European countries, SIOPE is leading the way to ensure the best possible care and outcomes for all children and adolescents with cancer in Europe.
 The ESO Partner for activities in a rare cancer is:

Rare Cancers Europe (RCE)

Rare Cancers Europe (RCE) has been established as a partnership of cooperating organisations that work together to place the issue of rare cancers firmly on the European policy agenda, to identify and promote appropriate solutions and to exchange best practice.
 The ESO Partner for educational activities on cancer in the elderly is:

International Society for Geriatric Oncology (SIOG)

The International Society of Geriatric Oncology, also called SIOG (Société Internationale d’Oncologie Gériatrique), is a multidisciplinary membership-based society with members engaged in more than 80 countries around the world. The goal of SIOG is to strenghten the capacity of health professionals in the field of geriatric oncology, in order to optimise treatment of older adults with cancer. 
 The ESO Partner for educational activities on Gynae-oncology is:

European Society of Gynaecological Oncology (ESGO)

The European Society of Gynaecological Oncology (ESGO) is a growing not-for profit organisation and forum of more than 3,400 professionals from across Europe and all around the world, dedicated to promoting the highest quality of care for women with gynaecological cancers.
The ESO Partners for the Medical Students Courses are:

European Society of Surgical Oncology (ESSO)

ESSO’s supports its members in advancing the science and practice of surgical oncology for the benefit of cancer patients. The Society aims to achieve this through a range of activities related to education, research and leadership in multidisciplinary care.

European Society for Radiotherapy and Oncology (ESTRO)

ESTRO fosters radiotherapy in all its aspects by setting standards in education and practice, facilitating research, stimulating exchange of scientific knowledge and promoting collaboration in radiotherapy in Europe and beyond as well as with other professions involved in cancer treatment.

European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. 
 ESO reccomends and supports the educational activites of:
St. Gallen Oncology Conferences

FOUNDATION SONK (St. Gallen Oncology Conferences)

Foundation SONK organises the St. Gallen Oncology Conferences in close cooperation with the ZeTuP Tumour and Breast Centre, a specialised non-profit centre for prevention, detection and treatment of cancer, especially breast cancer of the breast. ZeTuP is based in St. Gallen, Switzerland and is actively engaged in preventative and clinical cancer research.
www.zetup.ch - www.oncoconferences.ch



ESO is proud of its on-going role in the development of cancer patient advocacy in Europe. 

ESO launched two of the main breast and prostate cancer patient organisations in Europe. Our relationship continues to be an open, constructive collaboration with full mutual independence. We have also supported the European Cancer Patients Coalition and EuropaColon on different occasions, contributing to the establishment of Lung Cancer Europe.


Europa Donna

Europa Donna, the European Breast Cancer Coalition, is an independent non-profit organisation whose members are affiliated groups from countries throughout Europe. The Coalition works to raise awareness of breast cancer and to mobilise the support of European women in pressing for improved breast cancer education, appropriate screening, optimal treatment and increased funding for research. Europa Donna currently has 46 member countries. 

Europa Uomo

Europa Uomo (Italian for Europe man) is a European advocacy movement representing 27 prostate patients’ groups in countries across Europe. 

European Cancer Patient Coalition (ECPC)

With over 400 members, the European Cancer Patient Coalition (ECPC) is proud to be the largest European cancer patients’ association. Covering all 28 Member States, and many other European and non-European countries, ECPC represents those affected by all types of cancers, from the rarest to the most common.

Digestive Cancers Europe

Digestive Cancers Europe (DiCE) is the European umbrella organisation of a large group of national Members representing patients with digestive cancer – colorectal, gastric, pancreatic and rare cancers.
Lung Cancer Europe

Lung Cancer Europe

LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe.